Pneumocystis jirovecii pneumonia epidemiology and demographics: Difference between revisions
Created page with "{{Pneumocystis jirovecii pneumonia}} {{CMG}} ==Overview== ==References== {{reflist|2}} {{WH}} {{WS}} Category:Disease Category:Infectious disease" |
No edit summary |
||
| Line 2: | Line 2: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
Pneumocystis jirovecii pneumonia exists worldwide, in humans and animals. Serologic evidence indicates that most healthy children have been exposed by age 3 to 4. Pneumocystis pneumonia (PCP) occurs in immunosuppressed individuals and in premature, malnourished infants. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 17:05, 7 February 2012
|
Pneumocystis jirovecii pneumonia Microchapters |
|
Differentiating Pneumocystis jirovecii pneumonia from other Diseases |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Pneumocystis jirovecii pneumonia epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Pneumocystis jirovecii pneumonia epidemiology and demographics |
|
FDA on Pneumocystis jirovecii pneumonia epidemiology and demographics |
|
CDC on Pneumocystis jirovecii pneumonia epidemiology and demographics |
|
Pneumocystis jirovecii pneumonia epidemiology and demographics in the news |
|
Blogs on Pneumocystis jirovecii pneumonia epidemiology and demographics |
|
Risk calculators and risk factors for Pneumocystis jirovecii pneumonia epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Pneumocystis jirovecii pneumonia exists worldwide, in humans and animals. Serologic evidence indicates that most healthy children have been exposed by age 3 to 4. Pneumocystis pneumonia (PCP) occurs in immunosuppressed individuals and in premature, malnourished infants.